NHS Web-based Forward Planning Tool Aids Cancer Treatment on National Level

Many stakeholders are benefiting from the C-PORT project. Patients are benefitting from improved access to new therapies whilst witnessing shorter wait times on their chemotherapy treatment days. The government is gaining better understanding of variations in drug usage and clinical practices whilst gaining improved visibility on resources and patient mix at the national level. The NHS is taking a big step towards standardizing their evaluation of the impact new drugs make, planning their resources, and swiftly adapting clinical practices. Finally, even pharmaceutical companies are benefiting from a new approach to collaboration with the NHS, improving time-to-market for new drugs and proactively managing  uptake.

Download full case study